| BCBS Federal Medical & Drug | 5.21.146 Tabrecta (capmatinib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.147 Darzalex Faspro (daratumumab and hyaluronidase-fihj) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.148 Retevmo (selpercatinib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.150 Jelmyto (mitomycin) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.152 Zepzelca (lurbinectedin) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.153 Phesgo (pertuzumab, trastuzumab, hyaluronidase-zzxf) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.155 Tecartus (brexucabtagene autoleucel) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.156 Monjuvi (tafasitamab-cxix) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.160 Xeloda (capecitabine) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.161 Onureg (azacitidine) | 2026-03-06 |